Several African nations could strike a major blow against malaria by sacrificing the efficacy of some older drugs. Can they make it work?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
15 November 2013
This article wrongly attributed the quote “If we just roll this out without surveillance, we risk repeating all of the mistakes made in the past” to Paul Milligan instead of to Christopher Plowe. The text has now been corrected.
References
Plowe, C. V. Trans. R. Soc. Trop. Med. Hyg. 103, S11–S14 (2009).
Giglioli, G., Rutten, F. J. & Ramjattan, S. Bull. World Health Org. 36, 283–301 (1967).
Dicko, A. et al. Malar. J. 7, 123 (2008).
Cissé, B. et al. Lancet 367, 659–667 (2006).
Meremikwu, M. M., Donegan, S., Sinclair, D., Esu, E. & Oringanje, C. Cochrane Database Systematic Rev. 2012 http://dx.doi.org/10.1002/14651858.CD003756.pub4 (2012).
Cairns, M. et al. Nature Commun. 3, 881 (2012).
World Health Organization Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: A field guide (2012).
Author information
Authors and Affiliations
Additional information
See Editorial page 165
Related links
Related links in Nature Research
Related external links
Electronic supplementary material
A dose of prevention
Rights and permissions
About this article
Cite this article
Maxmen, A. Malaria: A race against resistance. Nature 503, 186–188 (2013). https://doi.org/10.1038/503186a
Published:
Issue date:
DOI: https://doi.org/10.1038/503186a